SRTA Strata Critical Medical Inc.

  1. Stocks
  2. Industrials
  3. NASDAQ: SRTA

Price (delayed)

$4.73

Market cap

$418.45M

P/E Ratio

9.65

Dividend/share

N/A

EPS

$0.49

Enterprise value

$406.12M

?
Relative Growth: Rel. Growth: 75
Relative Strength: Rel. Strength: 43
Relative Valuation: Rel. Valuation: 95
Relative Profitability: Rel. Profitability: 64
Highlights
The gross profit has soared by 84% YoY and by 13% QoQ
The revenue has soared by 67% year-on-year and by 12% since the previous quarter
The equity has increased by 25% year-on-year but it has declined by 2.2% since the previous quarter
The quick ratio has shrunk by 73% YoY and by 69% QoQ
SRTA's net income is down by 14% since the previous quarter
Sector: Industrials
Industry: Airports & Air Services
Website: https://www.blade.com
Peers: PINS

Key stats

What are the main financial stats of SRTA

SRTA stock price

How has the Strata Critical Medical stock price performed over time
Intraday
-2.07%
1 week
-11.26%
1 month
-12.24%
1 year
-9.56%
YTD
-1.66%
QTD
-7.44%

Financial performance

How have Strata Critical Medical's revenue and profit performed over time
Revenue
$255.98M
Gross profit
$52.62M
Operating income
-$20.41M
Net income
$40.22M
Gross margin
20.6%
Net margin
15.7%
The gross profit has soared by 84% YoY and by 13% QoQ
The revenue has soared by 67% year-on-year and by 12% since the previous quarter
Strata Critical Medical's operating margin has increased by 47% YoY and by 7% QoQ
The net margin is down by 24% since the previous quarter

Price vs fundamentals

How does SRTA's price correlate with its fundamentals

Growth

What is Strata Critical Medical's growth rate over time

Valuation

What is Strata Critical Medical stock price valuation
P/E
9.65
P/B
1.47
P/S
1.59
EV/EBIT
10.1
EV/EBITDA
7.19
EV/Sales
1.59
Strata Critical Medical's EPS has decreased by 13% QoQ
The equity has increased by 25% year-on-year but it has declined by 2.2% since the previous quarter
SRTA's P/B is 13% higher than its 5-year quarterly average of 1.3 but 2% lower than its last 4 quarters average of 1.5
The revenue has soared by 67% year-on-year and by 12% since the previous quarter
The stock's price to sales (P/S) is 34% less than its 5-year quarterly average of 2.4 and 21% less than its last 4 quarters average of 2.0

Efficiency

How efficient is Strata Critical Medical business performance
Strata Critical Medical's return on sales has decreased by 24% QoQ
The company's return on equity fell by 19% QoQ
The ROA has decreased by 19% QoQ
The ROIC has declined by 12% since the previous quarter

Dividends

What is SRTA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SRTA.

Financial health

How did Strata Critical Medical financials performed over time
The quick ratio has shrunk by 73% YoY and by 69% QoQ
The company's current ratio has shrunk by 56% YoY and by 55% QoQ
The debt is 98% smaller than the equity
The debt has dropped by 52% year-on-year and by 4.8% since the previous quarter
Strata Critical Medical's debt to equity has plunged by 50% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.